Healthcare >> CEO Interviews >> March 7, 2005
JONATHAN GOODMAN is the Founder, President and CEO of Paladin Labs Inc.,
an emerging, publicly-traded pharmaceutical company. Paladin's strategy
is to acquire, license and market innovative pharmaceuticals for the
Canadian market. Paladin has achieved eight consecutive years of record
revenues with revenues growing at a compound annual growth rate of 148%
since 1996. Since its founding, Paladin has been ranked as one of
Canada's 50 Best Managed Companies and one of Canada's fastest growing
technology companies. Mr. Goodman is a recipient of the Top 40 Under 40
award and was named Quebec Entrepreneur of the Year in the Life Sciences
Field by Ernst &Young. He is the youngest member of the Board of
Directors of Canada's Research Based Pharmaceutical Companies and
teaches an MBA course at McGill on pharmaceutical entrepreneurship. Profile
Mr. Goodman: Paladin is a specialty pharmaceutical company focused on
the Canadian market. The company was founded in 1996 and since that
time, our revenues have grown
